Nasdaq:QIPT
Quipt Home Medical Corp.
A manufacturer of high-end home medical devices and mobility solutions delivering critical care equipment to hospitals and aging populations.
Key Metrics
Investment Thesis
Bull Case
Quipt possesses a dominant market position in the growing home medical equipment sector fueled by demographic shifts toward aging populations; strong operating cash flow generation provides a buffer to fund R&D and potential acquisitions despite current accounting losses; the company's diversified product mix offers multiple revenue streams that can weather single-product cyclical downturns.
Bear Case
Persistent net losses and an accumulated deficit of $181.3M raise concerns about long-term viability without significant margin expansion or restructuring; high capital intensity with $12.4M in capex and heavy investing outflows may strain liquidity if revenue growth stalls; the company relies on external financing given negative cash flow from operations relative to net income adjustments.
About Quipt Home Medical Corp.
Quipt Home Medical Corp. designs and manufactures specialized home medical equipment, including durable mobility aids, power-operated lifts, and patient monitoring systems. The company serves healthcare providers, distributors, and end-users across North America and Europe with a focus on improving patient independence and care quality.
Analysis
Management Discussion
The company generated $37.7M in operating cash flow against a net loss of $10.6M, primarily driven by substantial depreciation of $39.4M and non-cash adjustments totaling $54.1M. Revenue remained stable at $245.4M compared to the prior year, but profitability deteriorated with losses widening from $6.8M to $10.6M, while cash reserves decreased by $3.0M due to significant investing outflows of $32.9M.
Industry Overview
The home medical equipment industry is experiencing robust growth driven by demographic aging, increased chronic disease prevalence, and post-pandemic shifts toward home-based care delivery. Regulatory changes and insurance reimbursement policies continue to shape competitive dynamics, favoring companies with established distribution networks and innovative product portfolios that address caregiver needs.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2024 | 2025 |
|---|---|---|
| Revenue | $245.9M | $245.4M |
| Cost of Revenue | $68.9M | $68.2M |
| Gross Profit | $177.0M | $177.2M |
| Operating Expenses | $175.9M | $181.0M |
| Operating Income | $1.1M | $-3.8M |
| Stock-Based Comp | $2.5M | $4.0M |
| D&A | $44.6M | $45.5M |
| Depreciation | $38.5M | $39.4M |
| Amortization | $6.1M | $6.1M |
| Non-Operating Income | $-7.8M | $-6.5M |
| Interest Income | $787.0K | $467.0K |
| Pre-Tax Income | $-6.7M | $-10.3M |
| Income Tax | $109.0K | $241.0K |
| Continuing Ops | $-6.8M | $-10.6M |
| Discontinued Ops | $0 | $0 |
| Net Income | $-6.8M | $-10.6M |
| Minority Interest | $0 | $121.0K |
| Net to Common | $-6.8M | $-10.7M |
| Metric | 2024 | 2025 |
|---|---|---|
| Current Assets | $73.1M | $78.3M |
| Cash & Equivalents | $16.2M | $12.9M |
| Accounts Receivable | $29.1M | $34.7M |
| Inventory | $20.9M | $25.6M |
| Prepaid Expenses | $6.9M | $5.1M |
| Other Current Assets | $0 | $0 |
| Long-Term Assets | $174.2M | $204.9M |
| PP&E (Net) | $37.4M | $46.1M |
| Goodwill | $50.7M | $61.6M |
| Other LT Assets | $84.8M | $96.3M |
| Total Assets | $247.2M | $283.3M |
| Current Liabilities | $60.9M | $74.7M |
| Accounts Payable | $29.3M | $38.4M |
| Other Current Liab | $31.5M | $36.3M |
| Long-Term Liabilities | $79.2M | $96.5M |
| Other LT Liab | $76.0M | $92.3M |
| Total Liabilities | $140.1M | $171.2M |
| Shareholders' Equity | $107.2M | $112.1M |
| Paid-In Capital | $277.8M | $281.7M |
| Retained Earnings | $-170.6M | $-181.3M |
| Total L&E | $247.2M | $283.3M |
| Metric | 2024 | 2025 |
|---|---|---|
| Net Income (CFO) | $-6.8M | $-10.6M |
| Non-Cash Adjustments | $30.1M | $54.1M |
| Working Capital Changes | $12.0M | $-5.8M |
| Cash from Operations | $35.4M | $37.7M |
| Capital Expenditures | $10.3M | $12.4M |
| Cash from Investing | $-10.3M | $-32.9M |
| Share Buybacks | — | $130.0K |
| Cash from Financing | $-26.1M | $-7.8M |
| FX Effect | $44.0K | $-247.0K |
| Net Change in Cash | $-1.1M | $-3.0M |
| Beginning Cash | $17.2M | $16.2M |
| Ending Cash | $16.2M | $12.9M |
Frequently Asked Questions
How does Quipt Home Medical Corp. make money?
Core revenue streams include durable medical equipment manufacturing for power mobility products like scooters and wheelchairs, patient handling systems such as hospital lifts and transfer devices, and ancillary services including product distribution and after-market support.
What are the main risks for QIPT?
Significant operating losses and an expanding retained earnings deficit indicating persistent profitability challenges; heavy capital expenditures relative to cash flow suggesting potential liquidity pressure; sensitivity to reimbursement rate changes in government-funded healthcare programs affecting demand for mobility aids.
What is QIPT's competitive advantage?
Strong brand recognition in the specialized home medical equipment market with a diverse product portfolio reducing reliance on single categories; established relationships with major healthcare system distributors ensuring steady order flow; robust R&D capabilities allowing for rapid integration of new assistive technologies.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.